Xiaowei Dong
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 8
- Advanced Drug Delivery Systems 5
- Advancements in Transdermal Drug Delivery 2
- Biomaterials 11
- Nanoparticle-Based Drug Delivery 11
- Co-authors
- Russell J. MumperMichael T. TsengCynthia A. MattinglyVal R. AdamsYang LiuMoo J. ChoPing MaMarkos Leggas
- Journals
- PLoS ONE (3 papers)Journal of Biomedical Nanotechnology (2 papers)International Journal of Pharmaceutics (2 papers)Pharmaceutics (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)
- Partner nations
- United StatesChinaHong Kong
In The Last Decade
Xiaowei Dong
38 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Biomaterials 679
- Pharmaceutical Science 282
- Neurology 152
- Oncology 349
- Molecular Biology 791
Countries citing papers authored by Xiaowei Dong
This map shows the geographic impact of Xiaowei Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Dong more than expected).
Fields of papers citing papers by Xiaowei Dong
This network shows the impact of papers produced by Xiaowei Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Dong. The network helps show where Xiaowei Dong may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Dong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 7 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 32 | |
| 11 | 2020 | 4 | |
| 12 | Current Strategies for Brain Drug Delivery Hit paper breakdown → | 2018 | 706 |
| 13 | 2017 | 4 | |
| 14 | 2016 | 38 | |
| 15 | 2016 | 11 | |
| 16 | 2016 | 16 | |
| 17 | 2009 | 137 | |
| 18 | 2008 | 73 | |
| 19 | 2003 | 3 | |
| 20 | Determination of Phospholipids in Soy Phospholipids by High Performance Liquid Chromatography | 2000 | 1 |
About Xiaowei Dong
Xiaowei Dong is a scholar working on Pharmaceutical Science, Biomaterials, Oncology, Analytical Chemistry and Spectroscopy, having authored 39 papers that have together received 1.9k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (11 papers), Drug Solubulity and Delivery Systems (8 papers), Analytical Chemistry and Chromatography (5 papers), Advanced Drug Delivery Systems (5 papers), Drug Transport and Resistance Mechanisms (3 papers), Chromatography in Natural Products (2 papers), HIV/AIDS drug development and treatment (2 papers) and Advancements in Transdermal Drug Delivery (2 papers). The work is most often cited by research in Biomaterials (679 citations), Pharmaceutical Science (282 citations), Neurology (152 citations), Oncology (349 citations) and Molecular Biology (791 citations). Xiaowei Dong has collaborated with scholars based in United States, China and Hong Kong. Frequent co-authors include Russell J. Mumper, Michael T. Tseng, Cynthia A. Mattingly, Val R. Adams, Yang Liu, Moo J. Cho, Ping Ma, Markos Leggas, Harry C. Ledebur and Anshul Gupte. Their work appears in journals such as PLoS ONE, Journal of Biomedical Nanotechnology, International Journal of Pharmaceutics, Pharmaceutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.